Introduction
Cytotoxic anticancer drugs elicit cellular stress responses which frequently produce a drugresistant phenotype. One important mechanism of resistance of tumor cells to chemotherapeutic agents is the overexpression of dimer proteins of the glutathione-S-transferase family (GSTs). 1 Thus, alkylating agents such as nitrogen mustards, cyclophosphamide, chlorambucil or melphalan, and other electrophile antitumor drugs such as busulfan or cis-platin, alter the expression of a number of genes that control glutathione and its associated enzymes, and many cancers show different distributions of GST isozymes compared to those seen in normal tissues. This knowledge suggests that selective GST inhibitors could provide potentiation of these chemotherapeutic agents. 2 The main role of GSTs is to promote the neutralization of electrophilic toxins by the intracellular tripeptide glutathione (γ-glutamylcysteinylglycine), 3 but these enzymes are also catalysts of eicosanoid biosynthesis, a mechanism that may also be important in anticancer chemotherapy owing to the involvement of those compounds in the control of cellular division. 4 In summary, inhibitors of glutathione synthesis (such as Lbuthionine sulfoximine 5 ) and GTS-inhibitors, 6 may help to prevent resistance to some antitumor agents. In fact, it has been shown that drugs like the diuretic ethacrynic acid or the anti-asthmatic compound piriprost, 1, 7 as well as some natural products, 8a,b potentiate the anticancer activity of alkylating agents because of their inhibitory effects on glutathione detoxification. Tryptophandehydrobutyrine diketopiperazine (TDD, 1), a fungal metabolite isolated from Streptomyces spectabilis and Streptomyces sp. MI513-bF5, is one of these natural products whose structure was reported in 1974 without a clear assignment of the configuration of the C-(2)-stereocenter and the stereochemistry of the exocyclic double bond. 8c,9a Owing to our interest in inhibitors of resistances to antitumor agents, 10 and the experience in aldol reactions with diketopiperazines, 11 we investigated the synthesis of 1 by condensation of acetaldehyde with N-acetyl derivatives of N 1 -methyl-cyclo-L-Trp-Gly by using a variety of reaction conditions. Rather unexpectedly, we only obtained N-deacetylation of the starting compound. This reaction failure, that was attributed to the steric constraints imposed by the N 1 -methyl and the 6-(3-indolylmethyl) substituents, moved us to prepare compound 1 and its E-isomer by dehydration of The chemical shifts of the vinylic protons in the Z-and E-isomers of 1 thus obtained, as well as the optical activity of the Z-isomer, supported the (6-S, Z)-configuration for this compound, but we found slight discrepancies between its melting point and some of its NMR and mass spectra data from those described for the natural product (Table 1) .
From these findings, we propose that the correct structure of TDD could be 2 instead of 1. The synthesis of compound 2, a regioisomer of 1 with the N-methyl group on the nitrogen adjacent to the ethylidene side-chain, is described here. 
Results and Discussion
The synthesis of compound 2 seemed, in principle, to be a simple problem. We knew that activation of cyclo-L-Trp-Gly (3, Scheme 2) by N-acetylation with acetic anhydride gave the N 1 ,N 4 ,N'-triacetylindolylmethylpiperazine-2,5-dione (4) and that this compound, through an aldol-type reaction with acetaldehyde in DMF and alumina-supported potassium fluoride as a base, 13 afforded the ethylidene derivative 7. This compound was supposed to be enantiomerically pure and seemed a good precursor of 2 by N-methylation and subsequent deacetylation. However, when we looked to this reaction sequence in depth we began to suspect that, given the low optical rotation values of compounds 4 and 7, 9b the N-acetylation and the subsequent condensation of 4 were not stereocontrolled as we had assumed. In fact, when the time for acetylation of 3 was increased to 12 hours, the compound 4 obtained was completely racemized.
To avoid the epimerization of the Trp-stereocenter, we decided to apply a procedure that we had developed previously for other synthetic objetives. 14 In agreement with this hypothesis, we observed that the tryptophan stereocenter of (+)-4 did not withstand the basic conditions that were required for its aldol-type condensation with acetaldehyde and, because this reaction proceeds with the anchimeric assistance of the vicinal Nacetyl group leading to its final elimination, compound 7 was obtained as a racemized product (Scheme 2). After considering the difficulties found in the preparation of homochiral (+)-7 and bearing in mind the fact that, with the exception of optical rotation, comparison of physical data of compounds 1 and 2 does not require enantiomeric purity, we undertook the preparation of (±)-4 by an alternative route, starting from non-chiral starting materials, in order to facilitate scale-up in its transformation into racemic compounds 7, 10 and 2 (Scheme 3). Compound (±)-4 was now obtained in 75% overall yield by reduction of 8, through a four-step procedure that started with indole-3-carbaldehyde and N 1 ,N 4 -diacetylpiperazine-2,5-dione (Scheme 3). 11b N-Methylation of compound 7, obtained by a second aldol-type condensation of 4 with acetaldehyde, required the total absence of water in order to avoid decomposition products. Fortunately, when anhydrous DMF and carefully dried sodium carbonate were used, compound 10 was obtained in very good yield. The chemical shift of it's α-ethylidene proton (δ = 5.70 ppm), as well as NOE experiments, confirmed the Z-configuration of its exocyclic double bond and, through a final deacetylation performed with hydrazine hydrate, we obtained the desired product (±)-2 with traces of its Eisomer. The significant differences observed by comparing data of compound 2 ( Table 2) with those reported for TDD and the synthetic product 1 (Table 1) permit us to conclude here that, in spite of the previously reported discrepancies, 9b structure 1 has to be the correct one for the natural product. A solution of 7 (38 mg, 0.11 mmol) in dry DMF was added to dried Na 2 CO 3 (23 mg, 0.22 mmol) and the mixture was stirred under argon at RT for 30 min. Then MeI (40 µl, 0.64 mmol) was added, the reaction mixture stirred at RT for 24 h, then extracted with AcOEt (10 mL x 3). The extracts were washed with H 2 O and saturated aq. NaCl, dried over anhydrous Na 2 SO 4 , filtered, and concentrated in vacuo to give 10 (45 mg), which was purified by flash chromatography on silica gel with hexane/ethyl acetate (1:1) as solvents yielding (10) 36 mg (92% 
